207 related articles for article (PubMed ID: 1550171)
1. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins.
Crook D; Cust MP; Gangar KF; Worthington M; Hillard TC; Stevenson JC; Whitehead MI; Wynn V
Am J Obstet Gynecol; 1992 Mar; 166(3):950-5. PubMed ID: 1550171
[TBL] [Abstract][Full Text] [Related]
2. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
Sendag F; Karadadas N; Ozsener S; Bilgin O
Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
[TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
Erenus M; Karakoç B; Gürler A
Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
6. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
7. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
[TBL] [Abstract][Full Text] [Related]
8. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
Godsland IF
Fertil Steril; 2001 May; 75(5):898-915. PubMed ID: 11334901
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.
Adami S; Rossini M; Zamberlan N; Bertoldo F; Dorizzi R; Lo Cascio V
Maturitas; 1993 Nov; 17(3):191-6. PubMed ID: 8133793
[TBL] [Abstract][Full Text] [Related]
10. Substitution of transdermal estradiol during oral estrogen-progestin therapy in postmenopausal women: effects on hypertriglyceridemia.
Sanada M; Tsuda M; Kodama I; Sakashita T; Nakagawa H; Ohama K
Menopause; 2004; 11(3):331-6. PubMed ID: 15167313
[TBL] [Abstract][Full Text] [Related]
11. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Ylikorkala O; Lim P; Caubel P
Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
[TBL] [Abstract][Full Text] [Related]
12. [Parameters of lipid metabolism in postmenopausal women on oral or transdermal hormone replacement with or without progesterone].
Foth D; Römer T; Benthin A
Zentralbl Gynakol; 2000; 122(9):483-8. PubMed ID: 11050765
[TBL] [Abstract][Full Text] [Related]
13. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
15. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
16. Oral versus transdermal hormone replacement therapy.
Stevenson JC; Crook D; Godsland IF; Lees B; Whitehead MI
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():30-5. PubMed ID: 8499957
[TBL] [Abstract][Full Text] [Related]
17. Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women.
Słowińska-Srzednicka J; Zgliczyński S; Chotkowska E; Srzednicki M; Stopińska-Głuszak U; Jeske W; Brzezińska A; Zgliczyński W; Sadowski Z
J Intern Med; 1993 Nov; 234(5):447-51. PubMed ID: 7693846
[TBL] [Abstract][Full Text] [Related]
18. Effect of estrogen-progestin replacement therapy on plasma lipids and lipoproteins in postmenopausal women.
Rodriguez-Alemán F; Torres JM; Cuadros JL; Ruiz E; Ortega E
Endocr Res; 2000 May; 26(2):263-73. PubMed ID: 10921452
[TBL] [Abstract][Full Text] [Related]
19. Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.
Hänggi W; Lippuner K; Riesen W; Jaeger P; Birkhäuser MH
Br J Obstet Gynaecol; 1997 Jun; 104(6):708-17. PubMed ID: 9197875
[TBL] [Abstract][Full Text] [Related]
20. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
